Sheena G Sullivan1, Shuo Feng, Benjamin J Cowling. 1. WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity , 792 Elizabeth St, Melbourne VIC 3000 , Australia.
Abstract
BACKGROUND: The test-negative design is a variant of the case-control study being increasingly used to study influenza vaccine effectiveness (VE). In these studies, patients with influenza-like illness are tested for influenza. Vaccine coverage is compared between those testing positive versus those testing negative to estimate VE. OBJECTIVES: We reviewed features in the design, analysis and reporting of 85 published test-negative studies. DATA SOURCES: Studies were identified from PubMed, reference lists and email updates. Study eligibility: All studies using the test-negative design reporting end-of-season estimates were included. STUDY APPRAISAL: Design features that may affect the validity and comparability of reported estimates were reviewed, including setting, study period, source population, case definition, exposure and outcome ascertainment and statistical model. RESULTS: There was considerable variation in the analytic approach, with 68 unique statistical models identified among the studies. CONCLUSION: Harmonization of analytic approaches may improve the potential for pooling VE estimates.
BACKGROUND: The test-negative design is a variant of the case-control study being increasingly used to study influenza vaccine effectiveness (VE). In these studies, patients with influenza-like illness are tested for influenza. Vaccine coverage is compared between those testing positive versus those testing negative to estimate VE. OBJECTIVES: We reviewed features in the design, analysis and reporting of 85 published test-negative studies. DATA SOURCES: Studies were identified from PubMed, reference lists and email updates. Study eligibility: All studies using the test-negative design reporting end-of-season estimates were included. STUDY APPRAISAL: Design features that may affect the validity and comparability of reported estimates were reviewed, including setting, study period, source population, case definition, exposure and outcome ascertainment and statistical model. RESULTS: There was considerable variation in the analytic approach, with 68 unique statistical models identified among the studies. CONCLUSION: Harmonization of analytic approaches may improve the potential for pooling VE estimates.
Entities:
Keywords:
case–control; influenza; public health; test-negative study; vaccine effectiveness
Authors: Jill M Ferdinands; Lauren E W Olsho; Anna A Agan; Niranjan Bhat; Ryan M Sullivan; Mark Hall; Peter M Mourani; Mark Thompson; Adrienne G Randolph Journal: J Infect Dis Date: 2014-03-26 Impact factor: 5.226
Authors: Silvia Jiménez-Jorge; Salvador de Mateo; Concha Delgado-Sanz; Francisco Pozo; Inmaculada Casas; Manuel Garcia-Cenoz; Jesús Castilla; Esteban Pérez; Virtudes Gallardo; Carolina Rodriguez; Tomás Vega; Carmen Quiñones; Eva Martínez; Juana María Vanrell; Jaume Giménez; Daniel Castrillejo; María del Carmen Serrano; Julián Mauro Ramos; Amparo Larrauri Journal: BMC Infect Dis Date: 2013-09-22 Impact factor: 3.090
Authors: Maria E Sundaram; David L McClure; Jeffrey J VanWormer; Thomas C Friedrich; Jennifer K Meece; Edward A Belongia Journal: Clin Infect Dis Date: 2013-09 Impact factor: 9.079
Authors: George Kafatos; Richard Pebody; Nick Andrews; Hayley Durnall; Michele Barley; Douglas Fleming Journal: Influenza Other Respir Viruses Date: 2013-09-16 Impact factor: 4.380
Authors: Jill M Ferdinands; Manjusha Gaglani; Emily T Martin; Don Middleton; Arnold S Monto; Kempapura Murthy; Fernanda P Silveira; H Keipp Talbot; Richard Zimmerman; Elif Alyanak; Courtney Strickland; Sarah Spencer; Alicia M Fry Journal: J Infect Dis Date: 2019-09-13 Impact factor: 5.226
Authors: Shuo Feng; Susan S Chiu; Eunice L Y Chan; Mike Y W Kwan; Joshua S C Wong; Chi-Wai Leung; Yiu Chung Lau; Sheena G Sullivan; J S Malik Peiris; Benjamin J Cowling Journal: Lancet Respir Med Date: 2018-11-12 Impact factor: 30.700
Authors: Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling Journal: J Infect Dis Date: 2019-10-08 Impact factor: 5.226